NCT00206596View on ClinicalTrials.gov

Study in Patients With Crohn's Disease Who Are Steroid Dependent, Despite Previous Unsuccessful Attempts to Reduce Steroids Due to Worsening of Crohn's Disease

PHASE2CompletedINTERVENTIONAL

Enrollment

127

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions

Crohn Disease

Interventions

DRUG

Sargramostim (Leukine)

Once daily via subcutaneous injection for up 22 weeks

DRUG

Placebo

Once daily via subcutaneous injection for up 22 weeks

All Listed Sponsors

lead

Genzyme, a Sanofi Company

INDUSTRY

NCT00206596 - Study in Patients With Crohn's Disease Who Are Steroid Dependent, Despite Previous Unsuccessful Attempts to Reduce Steroids Due to Worsening of Crohn's Disease | Biotech Hunter | Biotech Hunter